Clinical inertia in preventing cardiovascular mortality and prolonging the life of patients with type 2 diabetes mellitus and cardiovascular diseases

• Alexander S. Ametov
• Olga P. P'yanykh

Abstract

The disclosure of proven cardiorenal benefits with certain antidiabetic agents was supposed to herald a new era in the management of type 2 diabetes mellitus (T2DM), especially for the many patients with T2DM who are at high risk for cardiovascular and renal events. However, as the evidence in favour of various sodium-glucose transporter-2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) accumulates, prescriptions of these agents continue to stagnate, even among eligible, at-risk patients. We encourage all colleagues to play their part in overcoming clinical inertia to ensure that patients have a chance to reduce the risk of cardiovascular death and prolong life.

Keywords:type 2 diabetes mellitus, cardiorenal protection, glucose lowering drugs, clinical inertia

References

1. Schernthaner G., Shehadeh N., Ametov A.S., et al. Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes. Cardiovasc Diabetol. 2020: 19 (185). DOI: https://doi.org/10.1186/s12933–020–01154-w

2. Algorithms of specialized medical care for patients with diabetes mellitus. In: I.I. Dedov, M.V. Shestakova, A. Yu. Mayorov (eds). 9th issue, expanded. Moscow, 2019. DOI: https://doi.org/10.14341/DM221S1 (in Russian)

3. Strain W.D., Cos X., Hirst M., Vencio S., Mohan V., Vokó Z., et al. Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus. Diabetes Res Clin Pract. 2014; 105 (3): 302–12. DOI: https://doi.org/10.1016/j.diabres.2014.05.005 PMID: 24956964.

4. Verhestraeten, C., Heggermont, W.A. & Maris, M. Clinical inertia in the treatment of heart failure: a major issue to tackle. Heart Fail Rev. 2020. DOI: https://doi.org/10.1007/s10741–020–09979-z

5. Minakov E.V., Khokhlov R.A., Furmenko G.I., Akhmedzhanov N.M. Doctor inertness as a factor disturbing effective treatment of cardiovascular diseases. Ratsional’naya farmakoterapiya v kardiologii [Rational Pharmacotherapy in Cardiology]. 2009; (2): 39–48. DOI: https://doi.org/10.20996/1819–6446–2009–5–2–39–48 (in Russian)

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)